Cargando…
Combined replacement effects of human modified β-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts
GM2 gangliosidoses are autosomal recessive lysosomal storage diseases (LSDs) caused by mutations in the HEXA, HEXB and GM2A genes, which encode the human lysosomal β-hexosaminidase (Hex) α- and β-subunits, and GM2 activator protein (GM2A), respectively. These diseases are associated with excessive a...
Autores principales: | Kitakaze, Keisuke, Tasaki, Chikako, Tajima, Youichi, Hirokawa, Takatsugu, Tsuji, Daisuke, Sakuraba, Hitoshi, Itoh, Kohji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613250/ https://www.ncbi.nlm.nih.gov/pubmed/28955902 http://dx.doi.org/10.1016/j.bbrep.2016.04.012 |
Ejemplares similares
-
Therapeutic Potential of Intracerebroventricular Replacement of Modified Human β-Hexosaminidase B for GM2 Gangliosidosis
por: Matsuoka, Kazuhiko, et al.
Publicado: (2011) -
Thymic Alterations in GM2 Gangliosidoses Model Mice
por: Kanzaki, Seiichi, et al.
Publicado: (2010) -
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment
por: Toro, Camilo, et al.
Publicado: (2021) -
Functionality of a bicistronic construction containing HEXA and HEXB genes encoding β-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses
por: Shaimardanova, Alisa A., et al.
Publicado: (2021) -
The diagnostic journey for patients with late-onset GM2 Gangliosidoses
por: Lopshire, Mariah C., et al.
Publicado: (2023)